MBX Biosciences, Inc. MBX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s total equity?
- MBX Biosciences, Inc. (MBX) reported total equity of $437.76M in Q1 2026.
- How has MBX Biosciences, Inc.'s total equity changed year-over-year?
- MBX Biosciences, Inc.'s total equity increased by 85.9% year-over-year, from $235.42M to $437.76M.
- What is the long-term trend for MBX Biosciences, Inc.'s total equity?
- Over 3 years (2022 to 2025), MBX Biosciences, Inc.'s total equity has grown at a 105.4% compound annual growth rate (CAGR), from -$42.61M to $369.22M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.